Global Expansion Capitalize on Eko's international rollout in the United Kingdom and Canada to target health systems, academic medical centers, and ambulatory networks with the SENSORA AI platform and digital stethoscopes. Position the offering as regulatory-cleared, reimbursement-ready, and compatible with telehealth workflows to accelerate enterprise-wide adoption across Europe and North America.

Hospital Adoption Leverage existing hospital partnerships and the Wayne General Hospital case as a proof point to initiate pilots in emergency departments and primary care clinics, emphasizing AI-assisted detection, faster triage, and CPT billing capabilities to drive network-wide deployment across regional health systems.

Vet Market Explore the veterinary opportunity stemming from the Boehringer Ingelheim collaboration to market AI-based heart murmur detection in dogs, targeting veterinary clinics and universities, with co-marketed devices and analytics to create cross-industry revenue streams.

Partnerships Cred Utilize the appointment of a new Chief Medical Officer and ongoing Mayo Clinic and investor relationships to secure pilots and co-development agreements with large health systems, academic centers, and health technology partners, expanding referenceable deployments and data collaboration.

Telehealth Growth Promote the telehealth platform and real-time streaming capabilities to integrate with existing care delivery workflows, electronic health records and CRM ecosystems, offering a scalable solution for cardiac and pulmonary care across remote and underserved settings.